Edition:
United Kingdom

Karyopharm Therapeutics Inc (KPTI.OQ)

KPTI.OQ on NASDAQ Stock Exchange Global Select Market

18.51USD
14 Aug 2018
Change (% chg)

$0.50 (+2.78%)
Prev Close
$18.01
Open
$18.16
Day's High
$18.52
Day's Low
$17.97
Volume
137,187
Avg. Vol
256,302
52-wk High
$20.38
52-wk Low
$8.00

Select another date:

Thu, May 10 2018

BRIEF-Karyopharm Therapeutics Reports Q1 Loss Per Share Of $0.78

* KARYOPHARM REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND HIGHLIGHTS RECENT PROGRESS

BRIEF-Karyopharm Therapeutics Says Offering Shares Of Common Stock With Aggregate Offering Price Of $125 Mln

* KARYOPHARM THERAPEUTICS INC SAYS OFFERING SHARES OF CO'S COMMON STOCK WITH AN AGGREGATE OFFERING PRICE OF $125 MILLION - SEC FILING Source text : (https://bit.ly/2w3kEIH) Further company coverage:

BRIEF-Karyopharm Therapeutics Announces Proposed Public Offering Of Common Stock

* KARYOPHARM THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK

BRIEF-Karyopharm Announces Positive Top-Line Data From Phase 2b STORM Study Evaluating Selinexor In Patients With Penta-Refractory Multiple Myeloma

* KARYOPHARM ANNOUNCES POSITIVE TOP-LINE DATA FROM PHASE 2B STORM STUDY EVALUATING SELINEXOR IN PATIENTS WITH PENTA-REFRACTORY MULTIPLE MYELOMA

BRIEF-Karyopharm's Selinexor Receives Fast Track Designation From FDA

* KARYOPHARM'S SELINEXOR RECEIVES FAST TRACK DESIGNATION FROM FDA FOR THE TREATMENT OF PATIENTS WITH PENTA-REFRACTORY MULTIPLE MYELOMA

BRIEF-Karyopharm Therapeutics Reports Q4 Loss Per Share Of $0.80

* KARYOPHARM REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND HIGHLIGHTS RECENT PROGRESS

Select another date: